Key Findings
The North American market has seen a steady rise in the demand for the catheters since a majority of the Americans suffer from high cholesterol level that can be the main cause for blockade of arteries. The North America PTCA balloon catheters market is expected to proliferate at a CAGR of 3.43% during the forecasting years of 2019-2027.

Market Insights
The US and Canada are considered for the market study. The United States holds the largest share by revenue. The PTCA balloon catheters market is continuously increasing in the U.S. due to the increasing prevalence of cardiovascular disorders in people which is leading to rising in the usage of balloon catheters for removing the plaque formed in the coronary arteries, triggering a riot of CVDs.

Many clinical studies have failed to ascertain the complete safety and efficacy of various angioplasty balloons. These high-risk medical devices can cause adverse events, which may lead to their recall from the market.

Competitive Insights
The major market players operating in the North America region are Terumo Corporation, Microport Scientific Corporation, Cordis, Boston Scientific Corporation, Medtronic PLC, Endocor GmbH, C. R. Bard, Inc., Abbott Laboratories, Spectranetics, Biotronik Se & Co. KG, Cardinal Health Inc., Cook Medical LLC, and B Braun Melsungen AG.